Celanese Announces Vamac® AEM Price Increases
Celanese Corporation Reports First Quarter 2023 Earnings
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Celanese to Hold First Quarter Earnings Conference Call on May 10, 2023
Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments
Celanese Announces Hytrel® Price Increases
Celanese Corporation Reports Full Year 2022 and Fourth Quarter Earnings
Celanese and Mitsui & Co., Ltd. to Form Food Ingredients Joint Venture; Extend Existing Fairway Methanol LLC Joint Venture
Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton
